1. Home
  2. HESM vs HAE Comparison

HESM vs HAE Comparison

Compare HESM & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hess Midstream LP Share

HESM

Hess Midstream LP Share

HOLD

Current Price

$33.20

Market Cap

4.5B

Sector

Energy

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$83.09

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HESM
HAE
Founded
2014
1971
Country
United States
United States
Employees
N/A
3023
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
3.9B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
HESM
HAE
Price
$33.20
$83.09
Analyst Decision
Hold
Buy
Analyst Count
9
9
Target Price
$42.25
$88.38
AVG Volume (30 Days)
1.3M
671.6K
Earning Date
01-28-2026
02-05-2026
Dividend Yield
9.05%
N/A
EPS Growth
18.64
42.54
EPS
2.81
3.44
Revenue
$1,613,000,000.00
$1,327,850,000.00
Revenue This Year
$11.67
N/A
Revenue Next Year
N/A
$6.01
P/E Ratio
$11.89
$24.09
Revenue Growth
10.78
N/A
52 Week Low
$31.63
$47.32
52 Week High
$44.14
$87.32

Technical Indicators

Market Signals
Indicator
HESM
HAE
Relative Strength Index (RSI) 39.00 66.64
Support Level $34.20 $79.06
Resistance Level $34.82 $81.27
Average True Range (ATR) 0.49 1.55
MACD -0.14 -0.38
Stochastic Oscillator 2.42 88.74

Price Performance

Historical Comparison
HESM
HAE

About HESM Hess Midstream LP Share

Hess Midstream LP owns, operates, develops, and acquires a diverse set of midstream assets and provides fee-based services to Hess and third-party customers. It conducts its business through three operating segments: gathering, processing and storage, and terminaling and exporting. The company derives the maximum revenue from the gathering segment. Its gathering segment consists of the following assets namely Natural Gas Gathering and Compression; Crude Oil Gathering and Produced Water Gathering and Disposal.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: